Mauro Galeazzi Selected Research

Mauro Galeazzi Research Topics

Disease

42	Rheumatoid Arthritis 04/2020 - 06/2004
18	Uveitis 01/2020 - 08/2010
15	Necrosis 01/2020 - 02/2007
13	Rheumatic Diseases (Rheumatism) 04/2020 - 06/2007
13	Osteoarthritis 01/2018 - 06/2007
13	Infections 01/2017 - 09/2003
12	Inflammation (Inflammations) 01/2017 - 08/2004
11	Pain (Aches) 11/2017 - 02/2007
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2015 - 05/2002
9	Arthritis (Polyarthritis) 12/2019 - 10/2008
9	Fever (Fevers) 01/2015 - 07/2012
7	autosomal dominant familial Periodic fever 07/2017 - 06/2012
7	Knee Osteoarthritis 01/2017 - 02/2010
6	Autoimmune Diseases (Autoimmune Disease) 04/2016 - 10/2003
6	Systemic Scleroderma (Systemic Sclerosis) 03/2016 - 01/2008
6	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 03/2016 - 10/2003
6	Fibrosis (Cirrhosis) 01/2016 - 01/2008
5	Thrombosis (Thrombus) 09/2019 - 01/2008
5	Vasculitis (Vasculitides) 01/2018 - 04/2010
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 07/2017 - 06/2007
4	Psoriatic Arthritis 01/2020 - 01/2013
4	Behcet Syndrome (Behcet's Syndrome) 01/2020 - 07/2015
4	Ankylosing Spondylitis 09/2019 - 01/2014
4	Virus Diseases (Viral Diseases) 02/2014 - 10/2008
4	Osteoporosis 12/2013 - 09/2003
3	Joint Diseases (Joint Disease) 10/2017 - 04/2011
3	Cryopyrin-Associated Periodic Syndromes 10/2017 - 11/2012
3	Amyloidosis 07/2017 - 02/2012
3	Cardiac Arrhythmias (Arrythmia) 01/2017 - 01/2008
3	Gout 05/2016 - 01/2015
3	Type 2 Diabetes Mellitus (MODY) 06/2015 - 01/2015
3	Pericarditis 01/2015 - 07/2012
3	Bone Resorption 11/2014 - 03/2013
3	Mevalonate Kinase Deficiency 12/2013 - 11/2012
3	Congenital heart block 10/2011 - 01/2008
2	Sacroiliitis 11/2019 - 09/2019
2	Thrombophilia 09/2019 - 05/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 09/2019 - 01/2015
2	Atherosclerosis 09/2019 - 03/2013
2	Non-Radiographic Axial Spondyloarthritis 09/2019 - 07/2015
2	Axial Spondyloarthritis 09/2019 - 07/2018
2	Neoplasms (Cancer) 08/2019 - 05/2010
2	Overweight 03/2019 - 10/2017
2	Panuveitis 02/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

24	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 02/2007
15	Biological ProductsIBA 04/2020 - 06/2014
14	Pharmaceutical PreparationsIBA 12/2019 - 10/2008
13	Adalimumab (Humira)FDA Link 02/2019 - 06/2012
12	Infliximab (Remicade)FDA Link 02/2019 - 02/2007
12	AntibodiesIBA 11/2017 - 04/2004
11	InterleukinsIBA 01/2020 - 08/2010
11	AutoantibodiesIBA 11/2017 - 05/2002
10	Abatacept (Orencia)FDA Link 04/2020 - 01/2014
10	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2019 - 08/2006
9	Interleukin-1 (Interleukin 1)IBA 01/2020 - 11/2012
9	Immunosuppressive Agents (Immunosuppressants)IBA 08/2018 - 09/2003
9	Etanercept (Enbrel)FDA Link 01/2018 - 02/2007
9	CytokinesIBA 10/2015 - 08/2011
8	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 07/2012
8	Antirheumatic Agents (DMARD)IBA 03/2019 - 12/2012
7	ametantrone (HAQ)IBA 11/2017 - 02/2007
6	SteroidsIBA 07/2019 - 12/2012
6	Intravenous Immunoglobulins (IVIG)FDA Link 08/2018 - 12/2004
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2013 - 07/2007
5	C-Reactive ProteinIBA 09/2019 - 02/2007
5	MicroRNAs (MicroRNA)IBA 09/2019 - 01/2013
5	AdipokinesIBA 03/2019 - 11/2011
5	CannabinoidsIBA 03/2016 - 09/2009
5	InflammasomesIBA 01/2015 - 01/2013
5	Methotrexate (Mexate)FDA LinkGeneric 12/2014 - 05/2010
4	golimumab FDA Link 01/2020 - 07/2017
4	canakinumab FDA Link 01/2020 - 06/2012
4	Tumor Necrosis Factor InhibitorsIBA 11/2019 - 05/2013
4	tocilizumab (atlizumab)FDA Link 03/2019 - 09/2013
4	Interleukin-6 (Interleukin 6)IBA 03/2019 - 08/2008
4	Rheumatoid FactorIBA 10/2017 - 05/2016
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2017 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 03/2016 - 06/2004
3	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 09/2019 - 01/2008
3	Anticardiolipin AntibodiesIBA 09/2019 - 01/2008
3	Monoclonal AntibodiesIBA 03/2019 - 01/2017
3	AdiponectinIBA 03/2019 - 03/2013
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2018 - 08/2004
3	AntigensIBA 11/2017 - 04/2010
3	Rituximab (Mabthera)FDA Link 01/2017 - 12/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 08/2007
3	Fluorescein (Funduscein)FDA LinkGeneric 01/2017 - 01/2017
3	CollagenIBA 01/2016 - 03/2012
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016 - 04/2011
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 10/2015 - 09/2012
3	Colchicine FDA LinkGeneric 05/2015 - 08/2010
3	Proteins (Proteins, Gene)FDA Link 01/2013 - 01/2006
2	Biosimilar PharmaceuticalsIBA 12/2019 - 10/2016
2	factor V LeidenIBA 09/2019 - 05/2016
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 09/2019 - 05/2015
2	Prothrombin (Factor II)IBA 09/2019 - 05/2016

Therapy/Procedure

47	Therapeutics 11/2019 - 06/2004
5	Biological Therapy 12/2019 - 05/2015
5	Mud Therapy (Mud Bath) 01/2017 - 01/2011
2	Precision Medicine 01/2020 - 01/2013